Abstract:
A process of producing atracurium besylate that substantially reduces the level of impurities in the final product and avoids the repeated use of ether is provided. In accordance with such a process, N,N'-4,10-dioxa-3,11-dioxotridecylene-1,13-bis-tetrahydropapaverine (Compound 1), methyl benzenesulfonate and a catalytic amount of an insoluble base in a solvent are combined to form a reaction mixture that is maintained for a period of time sufficient for atracurium besylate formation. The reaction mixture is then filtered to remove the insoluble base and the atracurium besylate is precipitated.
Abstract:
Provided is a novel process for the preparation of iohexol having improved yields and purity, reduced number of isolated intermediates, and significantly reduced volume of ion-exchange resins required to desalinate the final product.
Abstract:
The hydroxy group of an epoxy-alcohol is selectively alkylated, without affecting the epoxy group, by reaction with an alkylating agent in the presence of a solvent and a strong base. As an example, Betaxolol (4) can be prepared according to scheme (1).
Abstract:
A method for the preparation D-chiro-inositol (I) from kasugamycin (II), comprising the steps of: (a) reacting kasugamycin with an acetylating agent to form a crude hexa-acetate intermediate; (b) purifying the crude intermediate to form purified hexa-acetate intermediate; (c) deacetylating the purified intermediate to form D-chiro-inositol; and (d) isolating the D-chiro-inositol. The method permits efficient, large-scale preparation of D-chiro-inositol without the need for extensive chromatographic purification of the final D-chiro-inositol product.
Abstract:
The hydroxy group of an epoxy-alcohol is selectively alkylated, without affecting the epoxy group, by reaction with an alkylating agent in the presence of a solvent and a strong base. As an example, Betaxolol (4) can be prepared according to scheme (1).
Abstract:
The process of the present invention relates to a process for producing 13-cis retinoic acid. The process of the present invention involves reacting a Wittig salt in a solvent with a butenolide in the presence of a weak base and optionally, a Lewis acid.
Abstract:
The process of the present invention relates to a process for producing 13-cis retinoic acid. The process of the present invention involves reacting a Wittig salt in a solvent with a butenolide in the presence of a weak base and optionally, a Lewis acid.